SynthesisEuropean journal of clinical pharmacology2022

Standard- vs. low-dose rivaroxaban in patients with atrial fibrillation: a systematic review and meta-analysis.

Guangyan Mu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.